Literature DB >> 31532345

Backward Hopf bifurcation in a mathematical model for oncolytic virotherapy with the infection delay and innate immune effects.

Yuxiao Guo1,2, Ben Niu1,2, Jianjun Paul Tian2,3.   

Abstract

In this paper, we consider a system of delay differential equations that models the oncolytic virotherapy on solid tumours with the delay of viral infection in the presence of the innate immune response. We conduct qualitative and numerical analysis, and provide possible medical implications for our results. The system has four equilibrium solutions. Fixed point analysis indicates that increasing the burst size and infection rate of the viruses has positive contribution to the therapy. However, increasing the immune killing infection rate, the immune stimulation rate, or the immune killing virus rate may lead the treatment failed. The viral infection time delay induces backward Hopf bifurcations, which means that the therapy may fail before time delay increases passing through a Hopf bifurcation. The parameter analysis also shows how saddle-node and Hopf bifurcations occur as viral burst size and other parameters vary, which yields further insights into the dynamics of the virotherapy.

Entities:  

Keywords:  34D20; 34K09; 37G10; Oncolytic virotherapy; backward Hopf bifurcation; infection delay; innate immune response

Mesh:

Year:  2019        PMID: 31532345      PMCID: PMC8881057          DOI: 10.1080/17513758.2019.1667443

Source DB:  PubMed          Journal:  J Biol Dyn        ISSN: 1751-3758            Impact factor:   2.726


  27 in total

1.  Efficient induction of cell death by adenoviruses requires binding of E1B55k and p53.

Authors:  B R Dix; S J O'Carroll; C J Myers; S J Edwards; A W Braithwaite
Journal:  Cancer Res       Date:  2000-05-15       Impact factor: 12.701

2.  A mathematical model of oncolytic virotherapy with time delay.

Authors:  Zi Zi Wang; Zhi Ming Guo; Hal Smith
Journal:  Math Biosci Eng       Date:  2019-03-06       Impact factor: 2.080

3.  A mathematical approach to effects of CTLs on cancer virotherapy in the second injection of virus.

Authors:  A Ashyani; O RabieiMotlagh; H M Mohammadinejad
Journal:  J Theor Biol       Date:  2018-05-18       Impact factor: 2.691

4.  Viruses as antitumor weapons: defining conditions for tumor remission.

Authors:  D Wodarz
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

Review 5.  Oncolytic viruses and their application to cancer immunotherapy.

Authors:  E Antonio Chiocca; Samuel D Rabkin
Journal:  Cancer Immunol Res       Date:  2014-04       Impact factor: 11.151

Review 6.  Oncolytic viruses.

Authors:  E Antonio Chiocca
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

7.  ODE models for oncolytic virus dynamics.

Authors:  Natalia L Komarova; Dominik Wodarz
Journal:  J Theor Biol       Date:  2010-01-18       Impact factor: 2.691

8.  Oncolytic activity of avian influenza virus in human pancreatic ductal adenocarcinoma cell lines.

Authors:  Samantha B Kasloff; Matteo S Pizzuto; Micol Silic-Benussi; Silvia Pavone; Vincenzo Ciminale; Ilaria Capua
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

9.  Modeling of cancer virotherapy with recombinant measles viruses.

Authors:  Zeljko Bajzer; Thomas Carr; Kresimir Josić; Stephen J Russell; David Dingli
Journal:  J Theor Biol       Date:  2008-02-01       Impact factor: 2.691

10.  The Role of the Innate Immune System in Oncolytic Virotherapy.

Authors:  Tuan Anh Phan; Jianjun Paul Tian
Journal:  Comput Math Methods Med       Date:  2017-12-12       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.